文献速递肾移植

肾移植受者GFR评估:肌酐、胱抑素C或联合方程?

Creatinine, cystatin C or both to estimate glomerular filtration rate in kidney transplant recipients?
PubMed 文献 · Nephrol Dial Transplant · 2026-01-01

本研究为多中心回顾性研究,纳入1348例稳定的法国和荷兰肾移植受者,以实测GFR为参考,比较CKD-EPI(2009/2021)与EKFC方程基于肌酐、胱抑素C或联合的效能。结果显示EKFC方程优于CKD-EPI对应方程,EKFCcrea+cys的P30最高(87.6%)且为唯一无偏联合方程;eGFRcrea与eGFRcys不一致常见(EKFC 42%,CKD-EPI >50%),联合方程在不一致组表现更佳。

要点

  • EKFC方程在肾移植受者中优于CKD-EPI对应方程。
  • EKFCcrea+cys的P30最高(87.6%),且为唯一无偏联合方程。
  • eGFRcrea与eGFRcys不一致常见,联合方程可改善准确性。

核心结论

  • EKFC方程尤其是EKFCcrea+cys在肾移植受者中提供更优的准确性。
  • eGFRcrea与eGFRcys不一致频繁,强化了联合方程的价值。

研究设计与样本

  • 多中心回顾性研究,纳入1348例来自法国和荷兰的稳定肾移植受者,以实测GFR为参考。

主要发现

  • EKFC方程在所有生物标志物上均优于CKD-EPI对应方程。
  • EKFCcrea+cys的P30最高(87.6%),且为唯一无偏联合方程。
  • eGFRcrea与eGFRcys不一致(差异>20%)常见:EKFC方程42%,CKD-EPI方程>50%。
  • 联合方程在不一致组表现更好,尤其是EKFC。
  • CKD-EPI方程在eGFRcrea低于eGFRcys的患者中表现不佳。

关键数值与推荐

  • 不一致定义为eGFRcrea与eGFRcys差异>20%。
  • EKFCcrea+cys的P30为87.6%。

临床怎么用

  • 在肾移植受者中可优先考虑EKFC方程,尤其是联合肌酐和胱抑素C的EKFCcrea+cys。
  • 当eGFRcrea与eGFRcys不一致时,联合方程可能提供更准确的评估。

局限性

  • 摘要未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Glomerular filtration rate (GFR) estimation is crucial in renal transplantation. While creatinine-based estimating equations (eGFRcrea) are widely used, their performance is suboptimal due to non-GFR determinants. Recent KDIGO guidelines recommend greater use of cystatin C-based equations, either alone (eGFRcys) or combined with creatinine (eGFRcrea+cys). This study compared the performance of Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) (2009/2021) and European Kidney Function Consortium (EKFC) equations in a large cohort of kidney transplant recipients, also analyzing discordance between eGFRcrea and eGFRcys. METHODS: This multicenter retrospective study included 1348 stable kidney transplant recipients from France and the Netherlands. Measured GFR (mGFR) served as the reference. Creatinine and cystatin C were measured using standardized assays. Performance was assessed using bias, P20, P30 and imprecision. Discordance was defined as >20% difference between eGFRcrea and eGFRcys. RESULTS: EKFC equations outperformed CKD-EPI counterparts for all biomarkers. EKFCcrea+cys had the highest P30 (87.6%) and was the only unbiased combined equation. Discordant eGFR results were common between eGFRcrea and eGFRcys (42% with EKFC, >50% with CKD-EPI). Combined equations showed better performance in discordant groups, particularly with EKFC. CKD-EPI equations performed poorly in patients with eGFRcrea lower than eGFRcys. CONCLUSION: EKFC equations-especially EKFCcrea+cys-provide superior accuracy in KTR. Discordance between eGFRcrea and eGFRcys is frequent, reinforcing the value of combined equations. Future studies should validate these findings across diverse populations and assess the prognostic impact of discordant GFR estimates.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Delanaye P, van Londen M, Vidal-Petiot E, et al. Creatinine, cystatin C or both to estimate glomerular filtration rate in kidney transplant recipients? Nephrol Dial Transplant. 2026. PMID: 41711602. doi:10.1093/ndt/gfag037

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。